Call
+918447748545

Published on: Jul 22, 2020
2 minute read
By: Dr Rajan Choudhary

The Oxford Vaccine

Recently we wrote a blog on the success of an RNA vaccine against SARS-CoV-2, the virus responsible for COVID-19. Within just a few weeks of that incredible research breakthrough, researchers at Oxford University’s Jenner Institute have announced a COVID vaccine that has induced remarkable immune response against the virus.

This study was published in the Lancet, one of the most prestigious medical journals in the world, and a simple summary suggests the vaccine has no early safety concern and is able to induce a strong immune response with both T cells and B cell/antibodies.

THE VACCINE

ChAdOx1 nCoV-19, now known as AZD1222, was co-developed by the University of Oxford and one of its spin-off companies, Vaccitech. The vaccine uses a viral vector based on a common cold virus (adenovirus). This carries genetic material for the SARS-CoV-2 spike protein. In our previous blog, we saw how the spike proteins are used by the virus to target and fuse with our target cells, allowing the virus to invade, replicate and ultimately cause the disease known as COVID. It is also a good target for the human immune system to recognize and attack.

The viral vector delivers the genetic material inside our cells. The spike protein is then produced by our cells, recognized by the immune system as a viral target, and an immune response is created against it. This can be antibodies, which recognize, attach to and mark the virus in our blood, allowing for other white blood cells to destroy the virus.

In this case, the vaccine also produced a T cell response. T cells can recognize cells infected by a virus-based on the markers present on the surface of infected cells. They can tell an infected cell to destroy itself, thereby destroying the virus within without spreading the infection. They also have other functions that we will not discuss in this blog.

THE STUDY

This study was a Phase I/II trial that started in April using the vaccine named ChAdOx1 nCoV-19. This vaccine development started in January 2020, and progress on development has been incredibly rapid. Whilst our previous study had just 45 people, this study looked reviewed over 1,000 healthy adults. 10 of these participants received two doses of the vaccine.

In a study the more participants there are, the greater the power of the study. If the vaccine has any side effects, even ones that rarely occur, it is more likely to be picked up in studies with more people. Similarly having more people helps show that the vaccine is effective, and the strong responses are not merely a fluke or accident. Another benefit of this study is it was able to compare the vaccine against a control group. This shows the results were not simply a placebo and allowed comparison of side effects as well.

The majority of side effects were feeling feverish, chills, muscle ache, headache, and malaise, all symptoms treatable with paracetamol. None of the participants had any serious side effects. It took just 14 days to create a T cell response, and 28 days to make strong antibodies. In 91% of patients, this was enough to neutralize the COVID coronavirus. Receiving two doses gave an even stronger antibody response, and all participants were able to stop the virus.

WHAT NEXT

The news from the University of Oxford is needed, as infection rate and mortality continue to increase in countries such as the US and Brazil. The ability to induce an antibody response without causing harm to the patient shows we have made huge progress in the fight against COVID-19. Further Large scale Phase III trials been set up through a global partnership, and include studies in the US with over 30,000 patients, studies in children as well as some in low to middle-income countries.

If successful a vaccine would be essential in preventing a second wave of COVID in the winter when the elderly population is most at risk. And it would be the key to restarting the economy and getting our everyday lives back to where it was pre-pandemic.

Read Blog

Telemedicine Platform Comparison India: Evaluating the Best Digital Healthcare Providers

Telemedicine has transformed the healthcare landscape in India by making medical services more accessible, affordable, and patient-friendly. With growing smartphone usage, improved internet penetration, and digital health adoption under the Ayushman Bharat Digital Mission (ABDM), teleconsultation platforms have become a primary mode of healthcare for millions. But with multiple platforms available, choosing the right one requires a proper telemedicine platform comparison India.

This blog provides a detailed comparison of India’s leading telemedicine providers and evaluates what sets SecondMedic apart in terms of accessibility, specialist availability, user experience, and overall digital healthcare value.

Why Telemedicine Is Growing Rapidly in India

The demand for digital healthcare platforms is driven by:

Busy lifestyles limiting hospital visits
Rising chronic diseases needing follow-ups
Rural populations needing specialist access
Post-pandemic digital health acceptance
Cost efficiency
Faster access to care

According to Statista, the telemedicine market size in India is increasing significantly, driven by digital transformation and patient willingness to adopt virtual care.

Key Parameters for Comparing Telemedicine Platforms

When comparing telemedicine platforms, users should evaluate the following:

1. Doctor Availability

The range of specialists available-cardiology, dermatology, pediatrics, gynecology, orthopedics, etc.-is crucial.

2. Pricing and Consultation Fees

Costs vary significantly between platforms. Affordable, transparent pricing determines long-term usability.

3. User Interface (UI/UX)

The platform must be easy to navigate, especially for elderly patients.

4. Appointment Wait Time

Faster access to doctors enhances the value of telemedicine.

5. E-Prescriptions

Availability of legal, digital prescriptions is essential for seamless continuity of care.

6. Electronic Health Records (EHR)

Platforms offering unified records improve patient experience.

7. Service Range

A good telemedicine platform should provide:

Teleconsultations
Second opinions
Remote monitoring
Home diagnostics
Preventive health packages

SecondMedic is one of the few platforms offering this full ecosystem.

Comparison of Major Telemedicine Platforms in India

1. SecondMedic

Specialties: Full range including cardiology, dermatology, neurology
Strengths:

Instant teleconsultation
Online specialist access
Remote monitoring tools
Second opinion services
Preventive health packages
Strong chronic care management
Patient-first experience
Easy EHR access
Best For: Those wanting comprehensive digital healthcare

2. Practo

Strengths:

Wide doctor network
Pharmacy integration
Lab test bookings
Limitations:
Higher consultation fees
Variable doctor response times

3. Apollo 24/7

Strengths:

Strong specialist network
Integration with Apollo hospitals
Limitations:
High cost
Limited remote monitoring features

4. Tata 1mg

Strengths:

Affordable consultations
Pharmacy + lab tests
Limitations:
Limited specialist variety
Heavy focus on diagnostics and medicines rather than telemedicine

5. MFine

Strengths:

Good specialist availability
Partner-hospital model
Limitations:
Service coverage varies
Less personalized care

This comparison shows that while multiple telemedicine platforms serve specific needs, SecondMedic provides a more integrated healthcare experience connecting consultations, preventive care, and chronic disease management.

What Makes SecondMedic Stand Out

1. Comprehensive Specialty Coverage

From general physicians to cardiologists, dermatologists, neurologists, endocrinologists, and pediatricians, SecondMedic covers major medical specialties.

2. Strong Chronic Disease Management

Continuous monitoring and scheduled check-ins help manage long-term conditions effectively.

3. Online Second Opinions

Patients needing specialist reassessment benefit from high-quality second opinions from top doctors.

4. Remote Monitoring Ecosystem

Compatible with digital ECGs, glucometers, BP monitors, and other wearable tools.

5. Affordable and Transparent Pricing

SecondMedic offers cost-effective consultations without hidden charges.

6. Easy-to-Use Interface

Designed for all age groups with minimal complexity.

7. Integration with Preventive Health Packages

Users can also book diagnostics, screenings, and wellness plans.

Importance of EHR in Telemedicine Platform Comparison India

Electronic Health Records improve:

Safety
Accuracy
Convenience
Treatment continuity

SecondMedic’s EHR system is aligned with ABDM guidelines, making health data secure and portable.

User Experience and Accessibility

A good telemedicine platform must offer:

Multilingual support
Low-bandwidth compatibility
Easy appointment scheduling
Quick report upload

SecondMedic excels in offering a smooth, user-friendly experience.

Future of Telemedicine Platforms in India

The next evolution includes:

AI-assisted triage
Wearable tech integration
Predictive health alerts
Virtual healthcare kiosks
Full ABDM interoperability

SecondMedic is aligning with these innovations to build the next-generation digital healthcare ecosystem.

Conclusion

Telemedicine platform comparison India reveals that while several platforms offer strong digital health services, SecondMedic stands out due to its integrated care model, specialist availability, chronic disease support, remote monitoring tools, and preventive healthcare programs. For patients seeking a complete, reliable, and patient-centric telemedicine experience, SecondMedic remains a top choice.

To explore telemedicine services, visit www.secondmedic.com

References

NITI Aayog - Telemedicine guidelines for India
Statista - Telemedicine adoption and market size
ABDM - Digital health mission framework
WHO - Teleconsultation standards
IMARC - Digital health ecosystem growth
SecondMedic platform insights

Request A Callback

+91

By using this website/app, I confirm that I am at least 18 years old and consent to the processing of my personal data in accordance with the Terms of Service, Privacy Policy, and Declaration.